JP2007519743A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519743A5
JP2007519743A5 JP2006551509A JP2006551509A JP2007519743A5 JP 2007519743 A5 JP2007519743 A5 JP 2007519743A5 JP 2006551509 A JP2006551509 A JP 2006551509A JP 2006551509 A JP2006551509 A JP 2006551509A JP 2007519743 A5 JP2007519743 A5 JP 2007519743A5
Authority
JP
Japan
Prior art keywords
composition
alkyl
aryl
substituted
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006551509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007519743A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/002755 external-priority patent/WO2005072408A2/en
Publication of JP2007519743A publication Critical patent/JP2007519743A/ja
Publication of JP2007519743A5 publication Critical patent/JP2007519743A5/ja
Withdrawn legal-status Critical Current

Links

JP2006551509A 2004-01-29 2005-01-31 ウイルス障害の処置 Withdrawn JP2007519743A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54042904P 2004-01-29 2004-01-29
US56048404P 2004-04-07 2004-04-07
PCT/US2005/002755 WO2005072408A2 (en) 2004-01-29 2005-01-31 Treating a viral disorder

Publications (2)

Publication Number Publication Date
JP2007519743A JP2007519743A (ja) 2007-07-19
JP2007519743A5 true JP2007519743A5 (enExample) 2008-03-06

Family

ID=34830506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006551509A Withdrawn JP2007519743A (ja) 2004-01-29 2005-01-31 ウイルス障害の処置

Country Status (6)

Country Link
US (1) US20050256181A1 (enExample)
EP (1) EP1734950A4 (enExample)
JP (1) JP2007519743A (enExample)
AU (1) AU2005208934A1 (enExample)
CA (1) CA2553814A1 (enExample)
WO (1) WO2005072408A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
JP2008514611A (ja) * 2004-09-23 2008-05-08 ワイス C型肝炎ウイルスによる感染を処置するためのカルバゾールおよびシクロペンタインドールの誘導体
WO2007047604A2 (en) * 2005-10-18 2007-04-26 Elixir Pharmaceuticals, Inc. Sirt1 inhibition
WO2008019825A1 (en) * 2006-08-14 2008-02-21 Santhera Pharmaceuticals (Schweiz) Ag Use of tricyclic indole derivatives for the treatment of muscular diseases
WO2008156656A2 (en) * 2007-06-13 2008-12-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Method for making biaryl compounds, compounds made by the method, and method for their use
US8568756B2 (en) * 2008-06-02 2013-10-29 The Trustees Of Princeton University Inhibition of quorum sensing-mediated processes in bacteria
MX2012004118A (es) * 2009-10-09 2012-05-08 Nestec Sa Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.
AR088377A1 (es) * 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
WO2017120409A1 (en) 2016-01-06 2017-07-13 Auspex Pharmaceuticals, Inc. Tetrahydrocarbazole inhibitors of sirt1 receptors
US20230255933A1 (en) * 2020-07-06 2023-08-17 Crescenta Biosciences Antiviral use of fabp4 modulating compounds
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011670A4 (en) * 1997-08-28 2004-10-27 Lilly Co Eli PROCESS FOR TREATING NON-RHUMATOID POLYARTHRITIS
EP1043991A4 (en) * 1997-11-14 2005-02-02 Lilly Co Eli TREATMENT OF ALZHEIMER DISEASE
US20040005574A1 (en) * 2002-07-08 2004-01-08 Leonard Guarente SIR2 activity
US7351542B2 (en) * 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity

Similar Documents

Publication Publication Date Title
JP2007529422A5 (enExample)
JP2007519743A5 (enExample)
JP2008513370A5 (enExample)
JP2008509166A5 (enExample)
JP2007505148A5 (enExample)
JP2007515429A5 (enExample)
AR042127A1 (es) Quinolinas, isoquinolinas y quinazolin- oxialquilamidas y sus usos como fungicidas
CA2495967A1 (fr) Nouveau procede de synthese et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent
HRP20140884T1 (hr) Derivati fenoksipiridinilamida i njihova primjena u lijeäśenju bolesnih stanja posredovanih inhibitorima pde4
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
JP2011513305A5 (enExample)
JP2002531564A5 (enExample)
IL177537A (en) Viral polymerase inhibitors, and pharmacological compounds containing them
JP2006518728A5 (enExample)
JP2011520792A5 (enExample)
JP2004523582A5 (enExample)
MX2009007482A (es) Agentes antiparasitarios.
JP2018530582A5 (enExample)
ZA200711080B (en) 1-(2-amino-3-(substituted alkyl)-3H-benzimidazoilymethyl)-3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
MY139027A (en) N-acylamino benzyl ether derivatives
WO2007083182A3 (en) Novel heterocycles
JP2017510645A5 (enExample)
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
US8222404B2 (en) [1,2,4]Thiadiazin-3-yl acetic acid compound and methods of making the acetic acid compound
WO2007031829A3 (en) Novel pyrimidine carboxamides